70 results
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
(including any civil, criminal, administrative, investigative, or appellate proceeding), hearing, inquiry, audit, examination, investigation or other
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
, administrative, investigative, or appellate proceeding), hearing, inquiry, audit, examination, investigation or other proceeding commenced, brought, conducted … with any investigation or other inquiry, including allowing the other Parties to have a reasonable opportunity to review in advance and comment on drafts
6-K
EX-99.1
BLU
Bellus Health Inc
29 Mar 23
Current report (foreign)
5:26pm
of participants with the disorder under investigation. We or the third parties we contract with may not be able to enroll a sufficient number
SUPPL
BLU
Bellus Health Inc
14 Nov 22
Supplemental materials (foreign)
5:25pm
require us or third parties we contract with to identify and enroll a large number of participants with the disorder under investigation. We or the third … CT Corporation System as our agent for service of process in the United States in connection with any investigation or administrative proceeding
6-K
EX-99.1
BLU
Bellus Health Inc
14 Nov 22
Open Market Sale Agreementsm
5:19pm
. There is no action, suit, proceeding, inquiry or investigation brought by or before any legal or governmental entity now pending or, to the knowledge … of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its subsidiaries or in connection
F-X
h3nzp3k6 1o
26 Aug 22
Appointment of agent for service of process by issuers registering securities
5:02pm
F-10
yp3nercr yv
26 Aug 22
Registration of securities (Canada)
4:48pm
SUPPL
n1h2g1 i7iqw
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
iwx8zv 83
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
borwxx 5hosq
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.1
ad20cwerb0947q1cjh
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.3
sgxjd88ok wfol4
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.1
5pxu8wf48r
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
gkbe4xx
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
SUPPL
m62vjntbpm 3rhi5
15 Dec 21
Supplemental materials (foreign)
5:10pm
F-X
bsp194 q4za4
14 Dec 21
Appointment of agent for service of process by issuers registering securities
10:42am
F-10
et1qmk52l evvyl
14 Dec 21
Registration of securities (Canada)
9:43am
SUPPL
5l4 6oy4128jzj83j25
13 Dec 21
Supplemental materials (foreign)
5:00pm
6-K
EX-99.1
iak746e ocb5m7
8 Apr 21
Bellus HEALTH 2020 ANNUAL REPORT
10:16am
40-F
EX-99.3
xjhu4
25 Feb 21
Annual report (Canada)
4:58pm